CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES
Jul 15, 2024
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
© 2024 CSRXP- All Rights Reserved
Press & Statements
CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Jul 11, 2024
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Jul 2, 2024
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
CSRXP APPLAUDS EXPANDED FTC CRACK DOWN ON BIG PHARMA’S SHAM PATENTS IN THE ORANGE BOOK
Apr 30, 2024
Commission Builds on Previous Action by Targeting More Than 300 Patents,… Read More
CSRXP COMMENDS PRESIDENT BIDEN FOR HOLDING BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE AND EGREGIOUS PRICING ON BRAND NAME INHALERS
Apr 3, 2024
President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press… Read More
Advisory: Panel Discussion on Big Pharma’s Patent Abuse with CSRxP Executive Director Lauren Aronson
Feb 6, 2024
Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable… Read More
CSRXP: BIG PHARMA’S JANUARY PRICE HIKES CLIMB TO 775 AS PHARMACEUTICAL INDUSTRY DOUBLES DOWN ON BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING
Jan 18, 2024
Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024… Read More
CSRXP: GSK’S FLOVENT SCHEME DESIGNED TO SIDESTEP ACCOUNTABILITY FOR EGREGIOUS PRICE HIKES
Jan 5, 2024
Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to… Read More
CSRXP: BIG PHARMA RINGS IN 2024 WITH EGREGIOUS PRICE HIKES ON HUNDREDS OF BRAND NAME PRESCRIPTION DRUGS
Jan 2, 2024
Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to… Read More
CSRXP: BIG PHARMA DOUBLES DOWN ON EGREGIOUS PRICE HIKES OUTPACING INFLATION
Dec 14, 2023
Administration Announces Drug Makers Increased Prices Faster Than Rate of… Read More
FACT SHEET: BIG PHARMA BRINGS INSULIN PRICE-GOUGING PLAYBOOK TO BLOCKBUSTER WEIGHT LOSS DRUGS
Dec 13, 2023
Big Pharma Eyeing Egregious Price Tags, Aggressive Marketing to Push GLP-1s… Read More
CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM
Nov 7, 2023
Commission Targets More Than 100 Patents on Brand Name Products Listed in the… Read More